Tom van Meerten, Marie José Kersten, Gloria Iacoboni, Georg Hess, Pim Mutsaers, Alejandro Martin Garcia-Sancho, Andre Goy, Eva Giné, Brian Hill, Wen-Kai Weng, Martin Dreyling, Patrick Reagan, Krish Patel, Ahmed Galal, Charles Herbaux, Robin Sanderson, Dan Zheng, Sabina Adhikary, Wangshu Zhang, Rita Damico Khalid, Ioana Kloos, Michael Wang. "Two-year update of ZUMA-2 Cohort 3: Brexucabtagene autoleucel (Brexu-cel) in patients (pts) with relapsed/refractory mantle cell lymphoma (R/R MCL) who had not received prior Bruton tyrosine kinase inhibitor (BTKi) therapy." Blood, 2025. doi:10.1182/blood-2025-1799